丝氨酸肽酶抑制因子Kazal型5(SPINK5)重组蛋白

丝氨酸肽酶抑制因子Kazal型5(SPINK5)重组蛋白

Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5)

LEKTI; LETKI; NETS; NS; VAKTI; Lymphoepithelial Kazal-Type-Related Inhibitor; Lympho-epithelial Kazal-type-related inhibitor

[ PROPERTIES ]

Source: Prokaryotic expression

Host: E.coli

Residues: Cys734~Ala995

Tags: N-terminal His Tag

Subcellular Location: Secreted

Purity: > 90%

Traits: Freeze-dried powder

Buffer formulation: 100mMNaHCO3

, 500mMNaCl, pH8.3, containing 0.01% SKL, 5%

Trehalose.

Original Concentration: 250µg/mL

Applications: Positive Control; Immunogen; SDS-PAGE; WB.

(May be suitable for use in other assays to be determined by the end user.)

Predicted isoelectric point: 7.5

Predicted Molecular Mass: 33.8kDa

Accurate Molecular Mass: 36kDa as determined by SDS-PAGE reducing conditions.

[ USAGE ]

Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.

[ STORAGE AND STABILITY ]

Storage: Avoid repeated freeze/thaw cycles.

 Store at 2-8ºC for one month.

 Aliquot and store at -80ºC for 12 months.

Stability Test: The thermal stability is described by the loss rate. The loss rate was determinedby accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and noobvious degradation and precipitation were observed. The loss rate is less than 5% within theexpiration date under appropriate storage condition.

[ SEQUENCE ]

[ IMPORTANT NOTE ]

The kit is designed for research use only, we will not be responsible for any issue if the kit wasused in clinical diagnostic or any other procedures.

特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！